Donoghue Forlines LLC acquired a new stake in shares of MetLife, Inc. (NYSE:MET - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 19,094 shares of the financial services provider's stock, valued at approximately $1,563,000.
Other hedge funds have also recently bought and sold shares of the company. MeadowBrook Investment Advisors LLC lifted its holdings in MetLife by 244.4% during the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider's stock worth $26,000 after acquiring an additional 220 shares during the period. Carmichael Hill & Associates Inc. raised its position in shares of MetLife by 131.9% in the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider's stock valued at $27,000 after purchasing an additional 186 shares during the period. Wolff Wiese Magana LLC lifted its position in shares of MetLife by 374.3% during the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider's stock worth $29,000 after acquiring an additional 277 shares in the last quarter. Peterson Financial Group Inc. purchased a new stake in MetLife during the 3rd quarter worth about $30,000. Finally, Retirement Wealth Solutions LLC bought a new position in shares of MetLife in the fourth quarter valued at approximately $32,000. 94.99% of the stock is owned by hedge funds and other institutional investors.
MetLife Trading Up 1.2 %
Shares of NYSE:MET traded up $1.06 during midday trading on Thursday, hitting $86.82. 3,399,772 shares of the stock traded hands, compared to its average volume of 3,541,914. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. The business's 50 day moving average is $83.68 and its two-hundred day moving average is $79.82. The stock has a market capitalization of $60.11 billion, a PE ratio of 17.50, a P/E/G ratio of 0.66 and a beta of 1.07. MetLife, Inc. has a one year low of $64.61 and a one year high of $89.05.
MetLife Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be issued a $0.545 dividend. This represents a $2.18 annualized dividend and a yield of 2.51%. The ex-dividend date is Tuesday, February 4th. MetLife's dividend payout ratio (DPR) is currently 43.95%.
Analyst Ratings Changes
Several equities analysts recently commented on MET shares. Jefferies Financial Group boosted their target price on MetLife from $89.00 to $95.00 and gave the stock a "buy" rating in a research report on Friday, September 27th. Barclays increased their price target on shares of MetLife from $90.00 to $96.00 and gave the stock an "overweight" rating in a report on Monday, January 6th. JPMorgan Chase & Co. increased their target price on MetLife from $86.00 to $88.00 and gave the company an "overweight" rating in a research note on Tuesday, January 7th. TD Cowen lifted their price target on MetLife from $97.00 to $99.00 and gave the stock a "buy" rating in a research note on Wednesday, November 27th. Finally, Piper Sandler increased their price objective on MetLife from $85.00 to $92.00 and gave the company an "overweight" rating in a research report on Wednesday, October 2nd. Two research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. Based on data from MarketBeat.com, MetLife has a consensus rating of "Moderate Buy" and an average target price of $90.46.
Check Out Our Latest Research Report on MET
MetLife Company Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.